(Q34351289)

1 August 2017

1 reference

title

Recurrent renal stone disease-advances in pathogenesis and clinical management (English)

1 reference

1 August 2017

G Bihl

1

1 reference

PubMed ID

11530173

1 August 2017

A Meyers

series ordinal

2

1 reference

PubMed ID

11530173

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

358

1 reference

1 August 2017

9282

1 reference

1 August 2017

651-656

1 reference

Observations on the analysis of ten thousand urinary calculi

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Lithogenic risk factors in normal black volunteers, and black and white recurrent stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Crystallization properties in urine from calcium oxalate stone formers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

The prothrombin gene is expressed in the rat kidney: Implications for urolithiasis research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Molecular characteristics of uronic-acid-rich protein, a strong inhibitor of calcium oxalate crystallization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Adhesion of uric acid crystals to the surface of renal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

A Simple Test for the Diagnosis of Absorptive, Resorptive and Renal Hypercalciurias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

The effectiveness of tenoxicam vs isosorbide dinitrate plus tenoxicam in the treatment of acute renal colic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

The stone clinic effect in patients with idiopathic calcium urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Should dietary calcium and protein be restricted in patients with nephrolithiasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Renal handling of citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

The pathogenesis and treatment of kidney stones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Effect of ethyl icosapentate on urinary calcium and oxalate excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

Treatment of cystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905782-8

7 January 2021

10.1016/S0140-6736(01)05782-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11530173